Revisiting HBV resistance to entecavir with a phenotypic approach
Texte intégral
Documents relatifs
A review of 13 trials in patients with decompensated HBV cirrhosis showed that entecavir compared to lamivudine reduced HBV DNA undetectability (moderate quality of evidence due
Bei dem hier vorliegenden Fall eines dif- fus großzelligen B-Zell-Lymphoms ist ei- ne systemische Immun- und Chemothe- rapie mit einem Rituximab-CHOP oder vergleichbarem
LK16, containing the fyuA gene, were also the only two strains in group A which showed positive 291.
• Comparison of the NS5B gene to HCV 1a and 1b reference strains, and recombinant 2k/1b described in Russia and Cyprus made us focus the region from E1 to NS3 to
The results of a study of risk fac- tors of tuberculosis treatment failure in the south-east of the Islamic Republic of Iran showed that family history of tuberculosis, weight
Derivation #2: HCC patients from the CiRCE study (n=56) were compared with patients with HCV-related chronic liver disease from two European cohorts (ANRS Genoscan study group,
The most severe potential consequence could be the treatment of the wrong pa- tient for a single session, possible in cases where the anatom- ical site to be treated was the same
This model, tailored to study failure propagation, is comprised of: two external functions, I1 and I2, that have no input (so, in their nominal state, the output is set to Ok);